leisure time -WSS

leisure time

author：focus 2025-09-06 05:26:40 - browse：1

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned.

One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT. Eisai, the drugmaker behind lecanemab, disagreed, pointing to other possible factors, including a series of setbacks in preceding months — multiple falls, a heart attack, a respiratory infection, and mini-stroke-like events.

Though still under investigation, the death suggests that new medicines to treat Alzheimer’s, like medicines to treat anything else, will come with their own side effects and costs. It also raises the importance of waiting for the full lecanemab data before drawing conclusions based on the positive press release put out by Eisai and its partner Biogen last month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Paxlovid rebound happens. Why and to whom are still a mystery

WSS

DOJ, FTC to increase scrutiny of all types of health care mergers

States increasingly look to regulate hospital facility fees

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

The kidney, in all its complexity, is captured in a new atlas

'Brian's Song' at 50 still offers lessons about cancer for today

Doctors push to include dialysis machines in emergency stockpile

hotspot

leisure time

focus

As demand for Covid shots wanes, Moderna seeks its next success

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

23andMe had bad news about my health. I wish a person had delivered it

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Drug repurposing or repositioning? The language matters

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Man who had jail sentence commuted by Trump arrested again

DIEP, the 'gold standard' of breast reconstruction, is under threat

Stanford updates investigation of president’s past research

knowledge

Election results set back Medicaid expansion plans

Celebrate National Dole Whip Day for 3 days this week at Disney

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

New warning issued for rebooking air travel after delays, cancellations

It was time to plan for my old age. If only I could stop crying

Couple fighting to bring baby home from Mexico are finally reunited

hotspot

hotspot

explore

explore